• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新思考携带纳洛酮回家。

Rethinking 'carriage' of take-home naloxone.

机构信息

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway.

出版信息

Int J Drug Policy. 2021 Sep;95:103253. doi: 10.1016/j.drugpo.2021.103253. Epub 2021 Apr 11.

DOI:10.1016/j.drugpo.2021.103253
PMID:33848942
Abstract

Take-home naloxone (THN) provision to people who use drugs, their family/friends, and non-medical personnel is considered a public health strategy to improve community-based naloxone access and reduce the time to antidote treatment for opioid overdose in order to prevent fatal outcome. THN programs typically report up to three performance indicators: the volume of THN kits distributed, the rate of requests for re-supply of THN kits (e.g., following naloxone use for overdose reversal), and - increasingly - THN "carriage". In this Research Methods piece, we discuss the current shortcomings in the latter measurement of THN carriage from a mixed-methods perspective and describe possible implications for public health related research and improved data analyses. We present an argument for the need to improve research methods in the case of THN "carriage" and propose a multidimensional measurement structure that takes into account: 1) the location of the THN kit relative to its owner, 2) the owner's immediate access to the kit in an emergency, 3) the type of THN device, and 4) the purpose of THN ownership (i.e., for use in self or known/unknown other/s).

摘要

向吸毒者、其家人/朋友和非医务人员提供可携带的纳洛酮(THN)被认为是改善社区纳洛酮获取途径和减少阿片类药物过量解毒剂治疗时间的公共卫生策略,以预防致命后果。THN 计划通常报告多达三个绩效指标:THN 试剂盒的分发量、THN 试剂盒再供应请求的比率(例如,在使用纳洛酮逆转过量后),以及——越来越多地——THN“携带”。在本研究方法部分,我们从混合方法的角度讨论了后者测量 THN 携带的当前缺陷,并描述了对与公共卫生相关的研究和改进数据分析的可能影响。我们提出了在 THN“携带”情况下改进研究方法的必要性,并提出了一个多维测量结构,该结构考虑到:1)THN 试剂盒相对于其所有者的位置,2)所有者在紧急情况下对试剂盒的即时访问,3)THN 设备的类型,以及 4)THN 所有权的目的(即,用于自我或已知/未知他人)。

相似文献

1
Rethinking 'carriage' of take-home naloxone.重新思考携带纳洛酮回家。
Int J Drug Policy. 2021 Sep;95:103253. doi: 10.1016/j.drugpo.2021.103253. Epub 2021 Apr 11.
2
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage.系统回顾和荟萃分析带离纳洛酮(THN)拥有和携带的流行率。
Int J Drug Policy. 2021 Oct;96:103298. doi: 10.1016/j.drugpo.2021.103298. Epub 2021 May 30.
3
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.带离式纳洛酮试剂盒:一项针对潜在药物过量目击者的欧洲调查的态度和使用意愿结果。
Eur Addict Res. 2022;28(3):220-225. doi: 10.1159/000521197. Epub 2022 Feb 3.
4
Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.不列颠哥伦比亚省与携带纳洛酮回家使用相关的因素:基于行政数据的分析。
Subst Abuse Treat Prev Policy. 2022 Mar 31;17(1):25. doi: 10.1186/s13011-022-00452-8.
5
Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.在繁忙的城市急诊部门,与提供纳洛酮带回家相关的患者特征:回顾性图表审查。
BMC Health Serv Res. 2019 Sep 5;19(1):632. doi: 10.1186/s12913-019-4469-3.
6
Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.过量用药教育和可携带纳洛酮套件的设计细节:与家庭医学、急诊部、成瘾医学和社区共同进行联合设计。
Health Expect. 2022 Oct;25(5):2440-2452. doi: 10.1111/hex.13559. Epub 2022 Jul 31.
7
Development of a take-home naloxone program at an urban academic emergency department.在城市学术急诊部门开发带教纳洛酮计划。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e324-e331. doi: 10.1016/j.japh.2020.06.017. Epub 2020 Jul 18.
8
Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.在急诊环境中分发可携带纳洛酮的随机对照试验是否可行和可接受?一项英国定性研究探索了阿片类药物使用者和急诊服务人员的观点。
BMC Emerg Med. 2024 Apr 29;24(1):75. doi: 10.1186/s12873-024-00987-y.
9
Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.用于预防海洛因及其他阿片类药物过量致死的带回家式纳洛酮二十年——构想与成熟历程
Drug Alcohol Depend. 2017 Sep 1;178:176-187. doi: 10.1016/j.drugalcdep.2017.05.001. Epub 2017 May 25.
10
Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.不列颠哥伦比亚省获取纳洛酮和社区药房的作用:基于行政数据的分析结果。
PLoS One. 2020 Sep 11;15(9):e0238618. doi: 10.1371/journal.pone.0238618. eCollection 2020.

引用本文的文献

1
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs.一项混合方法研究,旨在为加利福尼亚州圣地亚哥的致命过量预防提供信息:来自吸毒者的观点。
Int J Drug Policy. 2024 Nov;133:104577. doi: 10.1016/j.drugpo.2024.104577. Epub 2024 Sep 14.
2
Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic.在新冠疫情之前、期间和之后,对纽约市使用阿片类药物者的纳洛酮持有和携带情况的每周变化进行探索。
PLoS One. 2024 Jul 18;19(7):e0307151. doi: 10.1371/journal.pone.0307151. eCollection 2024.
3
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
瑞典首个带药回家纳洛酮项目:参与者特征、用药剂量终点及逆转过量用药的预测因素。
Subst Abuse Treat Prev Policy. 2023 Apr 22;18(1):24. doi: 10.1186/s13011-023-00533-2.
4
Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.在纽约市阿片类药物过量流行的芬太尼浪潮期间,注射吸毒者之间纳洛酮拥有情况存在差距,2018 年。
Subst Abus. 2022;43(1):1172-1179. doi: 10.1080/08897077.2022.2074597.